Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT06203236
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT06203236
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06203236. Randomized; double masking; primary purpose treatment. Start 2024-01 (anticipated); primary completion 2025-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
- Condition
- Acute Heart Failure
- Condition
- Chronic Kidney Diseases
- Intervention (Drug)
- Furosemide 20 MG
- Intervention (Other)
- diuretic therapy
- Lead sponsor
- Assiut University
Record details
- Record id
cardio:ct-nct06203236- Content hash
de797974892f664dcfea4d0a260e72dc3b6924b763dbe7c92a82a2f2a52d3a7b